Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Mebendazole 100mg price?When oxcarbazepine patent expired?When is the expected fda decision date for apotex's ruxolitinib resubmission?How many years does kadcyla's market exclusivity last?Does food increase lipitor's absorption?
See the DrugPatentWatch profile for Avastin
Avastin is a brand of bevacizumab, an anti-VEGF (vascular endothelial growth factor) cancer medicine. The manufacturer of Avastin in the United States is Genentech, Inc. [1]
Genentech is part of Roche. Avastin’s drug product and labeling are associated with Genentech for U.S. distribution/marketing [1].
Yes. The specific company listed as the marketing authorization holder or local distributor can vary by country, even though the active ingredient (bevacizumab) is the same. The most reliable source for a given country is the product’s local package insert or national regulator database. [1]
Bevacizumab is the active ingredient in Avastin and is manufactured by pharmaceutical manufacturers under Genentech/Roche’s product arrangements for the branded drug. For specifics beyond the brand manufacturer, the label/package insert for the country you’re in is the best reference. [1]
Check the box label or package insert for: - “Manufactured for” / “Distributed by” - The labeled marketing authorization holder - Country-specific company information Those details are listed in the prescribing information. [1] Sources: 1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761063
Other Questions About Avastin :